Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;28(8):1647-56.
doi: 10.1038/leu.2014.61. Epub 2014 Feb 7.

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors

Affiliations
Free article

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors

M Jourdan et al. Leukemia. 2014 Aug.
Free article

Abstract

The recent understanding of plasma cell (PC) biology has been obtained mainly from murine models. The current concept is that plasmablasts home to the BM and further differentiate into long-lived PCs (LLPCs). These LLPCs survive for months in contact with a complex niche comprising stromal cells (SCs) and hematopoietic cells, both producing recruitment and survival factors. Using a multi-step culture system, we show here the possibility to differentiate human memory B cells into LLPCs surviving for at least 4 months in vitro and producing immunoglobulins continuously. A remarkable feature is that IL-6 is mandatory to generate LLPCs in vitro together with either APRIL or soluble factors produced by SCs, unrelated to APRIL/BAFF, SDF-1, or IGF-1. These LLPCs are out of the cell cycle, express highly PC transcription factors and surface markers. This model shows a remarkable robustness of human LLPCs, which can survive and produce highly immunoglobulins for months in vitro without the contact with niche cells, providing the presence of a minimal cocktail of growth factors and nutrients. This model should be useful to understand further normal PC biology and its deregulation in premalignant or malignant PC disorders.

PubMed Disclaimer

References

    1. Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15 - PubMed
    1. Annu Rev Pathol. 2011;6:249-74 - PubMed
    1. Nat Immunol. 2003 Apr;4(4):321-9 - PubMed
    1. Nat Rev Immunol. 2006 Oct;6(10):741-50 - PubMed
    1. Nature. 1994 Mar 24;368(6469):339-42 - PubMed

Publication types

MeSH terms

Substances